Klein Lawrence Otto Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
1
Insider Buys Sum
$0
Insider Sells Quantity
7
Insider Sells Sum
$33.1M

Insider Activity of Klein Lawrence Otto

According to the SEC Form 4 filings, Klein Lawrence Otto, being in a position of

  1. Chief Executive Officer at Oruka Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 130910 shares for $11.79M,
    over all time since 2026-03-16, has bought 0 shares, and sold 130910 shares for $11.79M.

Biography of Klein Lawrence Otto

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$000
Sells
$11,794,7856100

Comparison of Insiders on Amount of Buys and Sells

2026-11-02SaleOruka Therapeutics, Inc.
ORKA
Chief Executive Officer
25,000
0.0398%
$95.61$2.39M+4.32%
2026-10-01SaleOruka Therapeutics, Inc.
ORKA
Chief Executive Officer
25,000
0.0416%
$83.62$2.09M-3.68%
2026-09-15SaleOruka Therapeutics, Inc.
ORKA
Chief Executive Officer
2,452
0.0042%
$95.71$234,681-8.69%
2026-09-01SaleOruka Therapeutics, Inc.
ORKA
Chief Executive Officer
75,000
0.124%
$91.83$6.89M-4.78%
2026-06-15SaleOruka Therapeutics, Inc.
ORKA
Chief Executive Officer
1,729
0.0046%
$69.69$120,494+33.08%
2026-03-16SaleOruka Therapeutics, Inc.
ORKA
Chief Executive Officer
1,729
0.0046%
$41.30$71,408+96.67%
2021-03-23SaleCRISPR Therapeutics AG
CRSP
CBO & COO
100,000
0.135%
$128.05$12.81M-13.65%
2021-01-15SaleCRISPR Therapeutics AG
CRSP
CBO & COO
25,000
0.0359%
$215.20$5.38M-40.49%
2020-08-07PurchaseDyne Therapeutics, Inc.
DYN
director
35,574
–
$0$0
2020-06-25SaleCRISPR Therapeutics AG
CRSP
CBO & COO
9,824
0.0158%
$75.18$738,545+50.82%
2020-06-24SaleCRISPR Therapeutics AG
CRSP
CBO & COO
127,263
0.2152%
$75.92$9.66M+56.83%
2020-05-11SaleCRISPR Therapeutics AG
CRSP
CBO & COO
50,000
0.0802%
$60.40$3.02M+67.83%
2019-07-11SaleCRISPR Therapeutics AG
CRSP
Chief Business Officer
16,842
0.0312%
$50.01$842,343+5.77%
2019-07-10SaleCRISPR Therapeutics AG
CRSP
Chief Business Officer
23,158
0.0237%
$27.94$647,035+4.35%
Total: 14
*Some uncertain data for Preferred Stock share type transactions are shown in italics; for actual data please follow the link
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.